Your browser doesn't support javascript.
loading
Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up.
Zhou, Hui; Xu-Monette, Zijun Y; Xiao, Ling; Strati, Paolo; Hagemeister, Fredrick B; He, Yizi; Chen, Huan; Li, Yajun; Manyam, Ganiraju C; Li, Yong; Montes-Moreno, Santiago; Piris, Miguel A; Young, Ken H.
Afiliação
  • Zhou H; Duke University Medical Center, Division of Hematopathology and Department of Pathology, Durham, NC, USA.
  • Xu-Monette ZY; Duke University Medical Center, Division of Hematopathology and Department of Pathology, Durham, NC, USA.
  • Xiao L; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Strati P; Department of Histology and Embryology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
  • Hagemeister FB; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • He Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chen H; Department of Lymphoma and Hematology, the Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha, Hunan, China.
  • Li Y; Department of Lymphoma and Hematology, the Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha, Hunan, China.
  • Manyam GC; Department of Lymphoma and Hematology, the Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha, Hunan, China.
  • Li Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Montes-Moreno S; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Piris MA; Servicio de Anatomía Patológica, Translational Hematopathology Lab, Hospital Universitario Marqués de Valdecilla/IDIVAL, Santander, Spain.
  • Young KH; Fundacion Jimenez Diaz; CIBERONC, Madrid, Spain.
Blood Cancer J ; 10(5): 49, 2020 05 04.
Article em En | MEDLINE | ID: mdl-32366834
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article